1.
Theocharides A, Passweg JR, Medinger M, Looser R, Li S, Hao-Shen H, Buser AS, Gratwohl A, Tichelli A, Skoda RC. The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica 2008; 93(12):1890-1893; https://doi.org/10.3324/haematol.13074.